Kevin Haynes

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc Effectiveness of an information technology intervention to improve prophylactic antibacterial use in the postoperative period
    Kevin Haynes
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, and Center for Education and Research on Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    J Am Med Inform Assoc 18:164-8. 2011
  2. pmc Temporal and within practice variability in the health improvement network
    Kevin Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Pharmacoepidemiol Drug Saf 20:948-55. 2011
  3. doi request reprint Cancer incidence in The Health Improvement Network
    Kevin Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:730-6. 2009
  4. doi request reprint Increased risk of digoxin toxicity following hospitalization
    Kevin Haynes
    Program for the Reduction in Medication Errors, Department of Biostatistics and Epidemiology and School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:28-35. 2009
  5. ncbi request reprint Inter-rater reliability of a classification system for hospital adverse drug event reports
    K Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Pharmacol Ther 83:485-8. 2008
  6. ncbi request reprint Declining public health burden of digoxin toxicity from 1991 to 2004
    K Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Pharmacol Ther 84:90-4. 2008
  7. doi request reprint Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events
    Charles E Leonard
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Epidemiol 61:561-71. 2008
  8. pmc Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events
    Joshua P Metlay
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Gen Intern Med 23:1589-94. 2008
  9. doi request reprint Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies
    Vincent Lo Re
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 21:1202-15. 2012
  10. pmc Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection
    Vincent Lo Re
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:807-14. 2009

Collaborators

Detail Information

Publications22

  1. pmc Effectiveness of an information technology intervention to improve prophylactic antibacterial use in the postoperative period
    Kevin Haynes
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, and Center for Education and Research on Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    J Am Med Inform Assoc 18:164-8. 2011
    ..Electronic order sets have shown promise as a means of integrating guideline information with electronic order entry systems and facilitating safer, more effective care...
  2. pmc Temporal and within practice variability in the health improvement network
    Kevin Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Pharmacoepidemiol Drug Saf 20:948-55. 2011
    ..However, little is known about the consistency within practices across observation years and among practices within a given year, in THIN or other large medical record databases...
  3. doi request reprint Cancer incidence in The Health Improvement Network
    Kevin Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:730-6. 2009
    ..This study assessed whether the recorded incidence of cancer among patients in The Health Improvement Network (THIN) database is comparable to that expected in the UK based on national cancer registry data...
  4. doi request reprint Increased risk of digoxin toxicity following hospitalization
    Kevin Haynes
    Program for the Reduction in Medication Errors, Department of Biostatistics and Epidemiology and School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:28-35. 2009
    ..The objective of the study was to identify health care system factors that affect the risk of digoxin toxicity for older adults on digoxin...
  5. ncbi request reprint Inter-rater reliability of a classification system for hospital adverse drug event reports
    K Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Pharmacol Ther 83:485-8. 2008
    ..Agreement on specific processes associated with ADEs ranged from poor to moderate, which limits the ability to target accurately processes to improve drug utilization...
  6. ncbi request reprint Declining public health burden of digoxin toxicity from 1991 to 2004
    K Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Pharmacol Ther 84:90-4. 2008
    ..The public health burden of digoxin toxicity declined dramatically from 1991 to 2004 in the United Kingdom and the United States...
  7. doi request reprint Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events
    Charles E Leonard
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Clin Epidemiol 61:561-71. 2008
    ..We sought to examine the validity of specific hospital discharge codes in identifying drug toxicity precipitating hospitalization, among elderly users of high-risk medications...
  8. pmc Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events
    Joshua P Metlay
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Gen Intern Med 23:1589-94. 2008
    ..Adverse drug events are an important cause of preventable hospitalizations...
  9. doi request reprint Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies
    Vincent Lo Re
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 21:1202-15. 2012
    ..To describe the design and rationale of a series of postmarketing studies to examine the safety of saxagliptin, an oral dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus, in real-world settings...
  10. pmc Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection
    Vincent Lo Re
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:807-14. 2009
    ..We determined the accuracy of HCV diagnostic codes within The Health Improvement Network (THIN), an electronic database containing medical record data from general medical practices in the United Kingdom...
  11. pmc Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study
    Joy Wan
    Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA
    BMJ 347:f5961. 2013
    ..To determine the risk of chronic kidney disease in patients with psoriasis...
  12. pmc Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study
    Ronac Mamtani
    Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Natl Cancer Inst 104:1411-21. 2012
    ..In this study, we assessed the risk of bladder cancer associated with the use of TZDs and between pioglitazone and rosiglitazone, an alternative TZD...
  13. pmc Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study
    Alexis Ogdie
    Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Ann Rheum Dis 73:149-53. 2014
    ..The objective of this study was to examine the risk of mortality in patients with PsA compared with matched controls, patients with psoriasis and those with rheumatoid arthritis (RA)...
  14. doi request reprint Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Pharmacoepidemiol Drug Saf 22:861-72. 2013
    ....
  15. pmc Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases
    Kevin Haynes
    University of Pennsylvania, Department of Epidemiology and Biostatistics, Philadelphia, PA 19104, USA
    Arthritis Rheum 65:48-58. 2013
    ..To compare the incidence of cancer following tumor necrosis factor α (TNFα) inhibitor therapy to that with commonly used alternative therapies across multiple immune-mediated diseases...
  16. doi request reprint Distinguishing incident and prevalent diabetes in an electronic medical records database
    Ronac Mamtani
    Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
    Pharmacoepidemiol Drug Saf 23:111-8. 2014
    ..To develop a method to identify incident diabetes mellitus (DM) using an electronic medical records (EMR) database and test this classification by comparing incident and prevalent DM with common outcomes related to DM duration...
  17. pmc Prevalence and treatment patterns of psoriatic arthritis in the UK
    Alexis Ogdie
    Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 8 Penn Tower, 1 Convention Ave, Philadelphia, PA 19104, USA
    Rheumatology (Oxford) 52:568-75. 2013
    ....
  18. doi request reprint Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms
    Manish Gopal
    Division of Urogynecology, University of Pennsylvania, Philadelphia, Pennsylvania 08901, USA
    Obstet Gynecol 112:1311-8. 2008
    ..To estimate the discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms in women...
  19. pmc Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease
    Michelle R Denburg
    Division of Nephrology, Department of Pediatrics, The Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Pharmacoepidemiol Drug Saf 20:1138-49. 2011
    ..The Health Improvement Network (THIN) in the UK represents a unique resource for population-based studies of CKD. We compiled a valid list of Read codes to identify subjects with moderate to advanced CKD...
  20. doi request reprint Physician attitudes toward regionalization of adult critical care: a national survey
    Jeremy M Kahn
    Division of Pulmonary, Allergy, and Critical Care, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Crit Care Med 37:2149-54. 2009
    ..Regionalization has been proposed as a method to improve outcomes for patients with critical illness. We sought to determine intensivist physician attitudes and potential barriers to the regionalization of adult critical care...
  21. ncbi request reprint Use of antiepileptic drugs in patients with kidney disease
    Rubeen K Israni
    Renal Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 19:408-16. 2006
    ..Monitoring of drug levels when available, careful clinical assessment of patients taking AEDs, and close collaboration with neurologists is essential to the management of patients taking AEDs...
  22. pmc Standards for head injury management in acute hospitals: evidence from the six million population of the Eastern region
    H M Seeley
    Neurosciences Department, Addenbrooke s Hospital, Cambridge, UK
    Emerg Med J 23:128-32. 2006
    ..To develop standards of care for head injury and thereby identify and prioritize areas of the service needing development; to report the findings from a survey of compliance with such standards in the Eastern region of UK...